Judge: Patent in Imclone case is Israelis
(AP)


AP - In a blow to ImClone Systems Inc., a federal judge ruled Monday that three scientists from Israel are the true inventors of a patent used for the company's blockbuster cancer drug, Erbitux, rather than seven people whose names are now on it.